Dapagliflozin 10mg Tablet
Reviewed educational reference: what Dapagliflozin is used for, how it works, its side effects and safety advice, plus the Indian brands that contain it.
- Molecule
- Dapagliflozin
- Strength
- 10mg
- Dosage form
- Tablet
- Drug class
- Sodium-glucose cotransporter 2 (SGLT2) inhibitor
Related products
No reviewed products are currently published for this generic.
Dapagliflozin 10mg Tablet contains Dapagliflozin, a potent and selective inhibitor of the sodium-glucose cotransporter 2 (SGLT2) in the proximal renal tubules. By inhibiting this transporter, Dapagliflozin 10mg Tablet reduces the reabsorption of filtered glucose from the tubular lumen, thereby increasing urinary glucose excretion. This mechanism lowers plasma glucose levels in patients with type 2 diabetes mellitus independently of insulin secretion or action. Beyond glycemic control, Dapagliflozin 10mg Tablet is also indicated for the management of heart failure and chronic kidney disease in specific patient populations.
At a glance
Dapagliflozin 10mg Tablet contains Dapagliflozin, an SGLT2 inhibitor.
It lowers blood sugar by increasing the amount of glucose excreted in the urine.
It is used to treat type 2 diabetes, heart failure, and chronic kidney disease.
Uses of Dapagliflozin
- Management of type 2 diabetes mellitus as an adjunct to diet and exercise.
- Reduction of the risk of hospitalization for heart failure in adults with heart failure.
- Treatment of chronic kidney disease to reduce the risk of sustained eGFR decline.
- Improvement of glycemic control in patients with inadequate response to metformin.
- Prevention of cardiovascular death in patients with established heart failure.
- Management of symptomatic heart failure with reduced ejection fraction.
Benefits of Dapagliflozin
Improved Glycemic Control
By promoting the excretion of excess glucose through the urine, Dapagliflozin 10mg Tablet provides a reliable and insulin-independent method to lower HbA1c levels. This action helps prevent the long-term microvascular and macrovascular complications associated with chronic hyperglycemia in diabetic patients.
Cardiovascular and Renal Protection
Clinical trials demonstrate that Dapagliflozin 10mg Tablet provides significant protection for the heart and kidneys. It reduces the risk of hospitalization due to heart failure and slows the progression of chronic kidney disease, making it a foundational therapy for patients with these comorbid conditions regardless of their diabetes status.
Side effects of Dapagliflozin
The most common side effects associated with Dapagliflozin 10mg Tablet include genital mycotic infections, such as vulvovaginal candidiasis and balanitis, which occur due to the increased glucose concentration in the urine. Urinary tract infections are also frequently reported. Patients may experience increased urination (polyuria) and volume depletion, which can lead to symptoms like dizziness, orthostatic hypotension, or dehydration, particularly in elderly patients or those taking diuretics. Rare but serious side effects include euglycemic diabetic ketoacidosis, a condition where blood glucose levels remain near normal while ketones are elevated, requiring immediate medical attention. Fournier's gangrene, a rare necrotizing fasciitis of the perineum, has also been reported and necessitates urgent surgical intervention if suspected.
| Side effect | How common | How severe | What to do |
|---|---|---|---|
| Genital mycotic infections | Common | Mild | Practice good hygiene and keep the genital area dry. |
| Urinary tract infections | Common | Moderate | Increase fluid intake to flush the urinary tract. |
| Volume depletion | Uncommon | Moderate | Ensure adequate daily water intake. |
How to manage side effects
Genital mycotic infections
- Consult a doctor for antifungal treatment.
- Maintain daily washing.
- Wear breathable cotton underwear.
Urinary tract infections
- Seek medical advice for antibiotic therapy.
- Monitor for fever or back pain.
- Complete the full course of prescribed antibiotics.
Volume depletion
- Monitor blood pressure regularly.
- Rise slowly from sitting positions.
- Report dizziness to your doctor.
How to use Dapagliflozin
- Take Dapagliflozin 10mg Tablet orally once daily, with or without food.
- Swallow the tablet whole with a glass of water, do not crush or chew it.
- Maintain adequate hydration throughout the day to minimize the risk of volume depletion.
- Follow the prescribed diet and exercise regimen consistently while taking this medication.
- Monitor your blood glucose levels regularly as advised by your healthcare provider.
- Do not stop taking Dapagliflozin 10mg Tablet without consulting your doctor, even if you feel well.
Special population advice
Kidney impairment
- Not recommended for initiation if eGFR < 25 mL/min/1.73m2.
- Monitor renal function periodically.
Liver impairment
- No dose adjustment needed for mild to moderate impairment.
- Use with caution in severe hepatic impairment.
Children
- Safety and efficacy not established in patients under 18 years.
- Do not use.
Elderly
- Monitor for volume depletion and orthostatic hypotension.
- Assess renal function before starting.
How Dapagliflozin works
Dapagliflozin selectively inhibits the SGLT2 protein in the proximal convoluted tubule of the kidney. Under normal conditions, SGLT2 is responsible for reabsorbing approximately 90% of filtered glucose back into the bloodstream. By blocking this transporter, Dapagliflozin 10mg Tablet forces the kidneys to excrete excess glucose into the urine, effectively lowering blood glucose levels and providing osmotic diuresis.
What if you miss or exceed a dose?
If you miss a dose
If you miss a dose of Dapagliflozin 10mg Tablet, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Do not take two doses at the same time to make up for a forgotten one, as this may increase the risk of side effects.
In case of overdose
In the event of an overdose, seek immediate medical attention or contact a poison control center. Symptoms of overdose are not well-defined but may include severe dehydration, extreme thirst, or significant electrolyte imbalances. Treatment is supportive, focusing on hydration and monitoring of blood glucose and electrolyte levels. Dapagliflozin is not effectively removed by hemodialysis.
Treatment is symptomatic and supportive.
- General Measures
- Discontinue the drug and monitor vital signs.
- Hydration
- Administer intravenous fluids if volume depletion is present.
- Glucose Monitoring
- Check blood glucose levels frequently.
- Electrolytes
- Monitor serum electrolytes and renal function.
Safety and precautions
When to avoid Dapagliflozin
- Hypersensitivity
Known allergy to dapagliflozin or any excipients.
- Dialysis
Patients on dialysis should not initiate or continue this therapy.
- Severe Renal Impairment
Efficacy is reduced in patients with severe kidney disease.
- History of Ketoacidosis
Increased risk of recurrence.
- Volume Depletion
Risk of hypotension in dehydrated patients.
- Urinary Tract Infections
May exacerbate active infections.
Safety at a glance
Excessive alcohol consumption may increase the risk of ketoacidosis and hypoglycemia.
Do not use during the second and third trimesters as it may affect fetal kidney development.
Consult your doctor; it is not known if this drug passes into breast milk.
Usually safe, but be cautious if you experience dizziness or low blood sugar.
Dose adjustment may be required based on eGFR; monitor kidney function regularly.
Use with caution in patients with severe hepatic impairment.
Do not take if you have a known hypersensitivity to dapagliflozin.
Not recommended for use in children under 18 years of age.
Increased risk of volume depletion and hypotension; monitor closely.
Interactions
With other medicines
Insulin secretagogues
ModerateChanges the medicine’s effect
What can happen: Increased risk of hypoglycemia.
What to do: Consider reducing the dose of the secretagogue.
Loop diuretics
ModerateChanges the medicine’s effect
What can happen: Increased risk of hypotension and dehydration.
What to do: Monitor blood pressure and hydration status closely.
Insulin
ModerateChanges the medicine’s effect
What can happen: Higher risk of hypoglycemia and ketoacidosis.
What to do: Adjust insulin dose as per blood glucose monitoring.
With food and drink
- High-sugar dietMinor
May counteract the glucose-lowering benefits of the medication.
- AlcoholModerate
Increases the risk of ketoacidosis and hypoglycemia.
If you have another condition
- Renal Impairment
Requires dose monitoring and potential discontinuation if eGFR falls below threshold.
- Hepatic Impairment
Use with caution due to limited data in severe cases.
- Hypotension
May worsen blood pressure levels in patients already prone to low BP.
Effect on laboratory tests
- Urine Glucose Test
Always positive
This is expected as the drug works by excreting glucose in urine.
- 1,5-anhydroglucitol (1,5-AG) assay
Unreliable
SGLT2 inhibitors interfere with this test; do not use it to monitor glycemic control.
Quick tips
- Maintain good personal hygiene to reduce the risk of genital infections.
- Check your feet daily for any sores or signs of infection, as diabetes increases this risk.
- Stand up slowly from a sitting or lying position to avoid dizziness caused by low blood pressure.
- Inform your doctor if you are scheduled for surgery, as you may need to pause this medication.
- Keep a record of your blood sugar readings to help your doctor adjust your treatment plan.
- Seek urgent care if you experience nausea, vomiting, abdominal pain, or confusion, which may signal ketoacidosis.
Counselling points
- Genital HygieneImportant
Maintain good hygiene to prevent fungal infections.
- HydrationImportant
Drink plenty of water to avoid dehydration.
- KetoacidosisImportant
Watch for symptoms like nausea, vomiting, and abdominal pain.
- HypoglycemiaGood to know
Be aware of signs of low blood sugar if taking insulin.
Monitoring during treatment
Before starting
- Renal function (eGFR)
- Blood pressure
- HbA1c
During treatment
- every 3 to 6 months: Monitor renal function and HbA1c levels.
- as needed: Check for signs of genital infections or urinary symptoms.
What is being watched
- eGFR
- Serum creatinine
- Blood glucose
- HbA1c
- Blood pressure
Pharmacokinetics
- Absorption
- Rapidly absorbed after oral administration.
- Bioavailability
- Approximately 78%.
- Protein binding
- About 91%.
- Volume of distribution
- 118 liters.
- Half-life
- Approximately 12.9 hours.
- Metabolism
- Primarily via UGT1A9 glucuronidation.
- Excretion
- Mainly through urine as metabolites.
- Onset / duration
- Onset within 24 hours; duration covers 24 hours.
Fact box
- Chemical class
- C-glucoside
- Habit forming
- No
- Therapeutic class
- Antidiabetic agent
- Action class
- Glucose-lowering agent
- Storage
- Store Dapagliflozin 10mg Tablet at room temperature, between 20°C and 25°C, in a dry place away from moisture and direct sunlight. Keep the container tightly closed and out of reach of children.
- ATC code
- A10BK01
- Pregnancy category
- Category D
More information
Why Clinicians Prioritize SGLT2 Inhibitors
Clinicians increasingly favor Dapagliflozin as a first-line or early add-on therapy because it offers benefits that extend well beyond simple glucose reduction. Unlike traditional oral hypoglycemic agents that primarily target insulin resistance or secretion, Dapagliflozin addresses the renal handling of glucose. This unique mechanism provides a 'cardiorenal' protective effect, which has been validated in large-scale clinical trials. For patients with type 2 diabetes who also have established cardiovascular disease or chronic kidney disease, Dapagliflozin is often chosen because it actively reduces the risk of heart failure hospitalization and slows the progression of kidney damage, providing a holistic approach to managing the complex metabolic and systemic risks associated with diabetes.
Comparing Dapagliflozin with Traditional Alternatives
When compared to older classes like sulfonylureas, Dapagliflozin offers a significantly lower risk of hypoglycemia, as its action is independent of insulin levels. Unlike metformin, which is primarily a hepatic glucose regulator, Dapagliflozin works by promoting the excretion of glucose, which also leads to a modest reduction in body weight and blood pressure. While metformin remains the gold standard for initial therapy due to its safety profile and cost-effectiveness, Dapagliflozin is frequently introduced when patients require additional glycemic control or when they present with specific comorbidities like heart failure or reduced eGFR. It is not a replacement for insulin in type 1 diabetes, but it serves as a powerful tool in the modern management of type 2 diabetes and related organ dysfunction.
Lifestyle and Diet During Treatment
Taking Dapagliflozin does not eliminate the need for a healthy lifestyle. Patients are encouraged to maintain a balanced diet that is low in refined sugars and saturated fats to support the medication's glucose-lowering effects. Because Dapagliflozin induces a mild osmotic diuresis, staying well-hydrated is essential to prevent dizziness and orthostatic hypotension. Regular physical activity is also vital, as it enhances insulin sensitivity and cardiovascular health. Patients should be particularly mindful of foot care, as diabetes-related neuropathy can mask injuries, and the increased glucose in the urine can potentially create an environment conducive to skin infections if hygiene is neglected. Consistent monitoring of blood sugar levels remains a cornerstone of successful therapy.
What to Expect Over a Course of Treatment
Upon starting Dapagliflozin, patients may notice an increase in the frequency and volume of urination, which is a normal physiological response to the drug's mechanism of action. This effect typically stabilizes over time. Over the first few weeks, patients often observe a gradual improvement in their HbA1c levels and may experience a slight reduction in body weight. It is important to attend all scheduled follow-up appointments, as the clinician will need to monitor renal function and electrolyte balance, especially in the first few months. If any symptoms of genital discomfort or signs of urinary tract infection appear, these should be reported promptly to the healthcare provider. Long-term treatment with Dapagliflozin is generally well-tolerated and provides sustained protection for the heart and kidneys.
References
- Medicines.org.uk. Dapagliflozin 10mg Film-coated Tablets, Summary of Product Characteristics.View sourceAccessed
- European Medicines Agency. Dapagliflozin Viatris, Product Information.View sourceAccessed
- National Agency for Food and Drug Administration and Control. Dapagliflozin 10mg SmPC.View sourceAccessed
- Medical Products Agency Sweden. Dapagliflozin Reddy SmPC.View sourceAccessed
- Tripathi KD. Essentials of Medical Pharmacology. 8th ed. Jaypee Brothers Medical Publishers, 2019. p. 294, 301, 303.Accessed
Frequently asked questions about Dapagliflozin
Does Dapagliflozin 10mg Tablet cause weight loss?
Yes, many patients experience modest weight loss while taking Dapagliflozin 10mg Tablet due to the loss of glucose calories in the urine.
Can I take Dapagliflozin 10mg Tablet if I have type 1 diabetes?
No, Dapagliflozin 10mg Tablet is not indicated for type 1 diabetes and may increase the risk of diabetic ketoacidosis.
Will I get more urinary tract infections?
Yes, because sugar in the urine promotes bacterial growth, you are at a higher risk for genital and urinary tract infections.
Should I stop taking Dapagliflozin 10mg Tablet before surgery?
Yes, it is generally recommended to pause Dapagliflozin 10mg Tablet a few days before major surgery to reduce the risk of ketoacidosis.
Does Dapagliflozin 10mg Tablet affect my blood pressure?
It may cause a small reduction in blood pressure due to its diuretic effect, which is generally beneficial but requires monitoring.
Most bought this month
1Crocin Advance 500 TabletGlaxoSmithKline Pharmaceuticals Ltd₹22.25
2Glycomet 500 TabletUSV Pvt Ltd₹18.80
3Mox 500 CapsuleSun Pharmaceutical Industries Ltd₹72.80
4Cetzine TabletGlaxoSmithKline Pharmaceuticals Ltd₹25.70
5Calpol 650 TabletGlaxoSmithKline Pharmaceuticals Ltd₹30.50
Ranked by how often readers opened a partner link in the last 30 days.
All medicines →